Insufficient insulin secretion resulting from either loss of β cell mass in type 1 diabetes or β cell dysfunction in type 2 diabetes (T2D) manifests as hyperglycemia and contributes to increased morbidity and mortality (1). Here, INS is linked to Hyperglycemia.